VU-0238429
(Preusmjereno sa stranice CKLGZXFOLMHCMC-UHFFFAOYSA-N)
VU-0238429 je lek koji deluje kao selektivni pozitivni alosterni modulator za muskarinski acetilholinski receptor M5. On je bio prvi selektivni ligand razvijen za M5 podtip.[5] VU-0238429 je strukturni derivat raznije otkrivenih M1-selektivnih pozitivnih alosternih modulatora poput VU-0119498.[6][7]
(IUPAC) ime | |||
---|---|---|---|
1-(4-metoksibenzil)-5-(trifluorometoksi)indol-2,3-dion | |||
Klinički podaci | |||
Identifikatori | |||
ATC kod | ? | ||
PubChem[1][2] | 42633508 | ||
ChemSpider[3] | 24606034 | ||
ChEMBL[4] | CHEMBL466253 | ||
Hemijski podaci | |||
Formula | C17H12F3NO4 | ||
Mol. masa | 351,276 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
Reference uredi
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Bridges TM, Marlo JE, Niswender CM, et al. (June 2009). „Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins”. Journal of Medicinal Chemistry 52 (11): 3445–8. DOI:10.1021/jm900286j. PMID 19438238.
- ↑ Conn PJ, Jones CK, Lindsley CW (March 2009). „Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders”. Trends in Pharmacological Sciences 30 (3): 148–55. DOI:10.1016/j.tips.2008.12.002. PMC 2907736. PMID 19201489.
- ↑ Bridges T. M., Kennedy J. P., Hopkins C. R., Conn P. J., Lindsley C. W. (2010). „Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators”. Bioorganic & Medicinal Chemistry Letters 20 (19): 5617. DOI:10.1016/j.bmcl.2010.08.042.